Reports Q4 revenue $145.95M, consensus $136.43M. “We are pleased with our strong finish to 2023 and continued momentum as we enter 2024,” said Brent Guerisoli, Pennant’s CEO. “By executing on our five key focus areas–leadership development, clinical excellence, employee engagement, margin improvement, and growth–we made steady gains throughout 2023 and solidly delivered on earnings expectations, even after increasing guidance during the year. With a talented group of leaders and teams in operations throughout our footprint and compelling growth opportunities available to us, we are excited to accelerate our performance in 2024.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PNTG:
- Pennant Group Inc Unveils New Investor Presentation Online
- Pennant Reports Fourth Quarter and Fiscal Year 2023 Results
- Pennant Announces Fourth Quarter and Year-End 2023 Earnings Release and Call
- Stephens upgrades Pennant Group on potential to beat 2024 estimates
- Pennant Group upgraded to Overweight from Equal Weight at Stephens
